Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs.
Ellen ChildsSabrina A AssoumouKatie B BielloDea L BiancarelliMari-Lynn DrainoniAlberto EdezaPeter SalhaneyMatthew J MimiagaAngela Robertson BazziPublished in: Harm reduction journal (2019)
Our findings highlight persistent beliefs among PWID that hinder HCV treatment utilization. Given the strong evidence that treatment improves individual health regardless of substance use status while also decreasing HCV transmission in the population, efforts are urgently needed to counter the predominant narratives identified in our study. We provide evidence-based, guideline-adherent information that counters the identified narratives in order to help individuals working with PWID to motivate and facilitate treatment access and uptake. An important strategy to improve HCV treatment initiation among PWID could involve disseminating guideline-concordant counternarratives to PWID and the providers who work with and are trusted by this population.